Tags

Type your tag names separated by a space and hit enter

WHO COVID-19 therapeutic guidelines.
Lancet. 2021 07 10; 398(10295):117-118.Lct

Authors+Show Affiliations

McMaster University, Hamilton, ON, Canada.University of Geneva, Geneva, Switzerland.World Health Organization, 1202 Geneva, Switzerland.World Health Organization, 1202 Geneva, Switzerland. Electronic address: askiel@who.int.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

34246341

Citation

Rochwerg, Bram, et al. "WHO COVID-19 Therapeutic Guidelines." Lancet (London, England), vol. 398, no. 10295, 2021, pp. 117-118.
Rochwerg B, Agoritsas T, Diaz J, et al. WHO COVID-19 therapeutic guidelines. Lancet. 2021;398(10295):117-118.
Rochwerg, B., Agoritsas, T., Diaz, J., & Askie, L. (2021). WHO COVID-19 therapeutic guidelines. Lancet (London, England), 398(10295), 117-118. https://doi.org/10.1016/S0140-6736(21)01331-3
Rochwerg B, et al. WHO COVID-19 Therapeutic Guidelines. Lancet. 2021 07 10;398(10295):117-118. PubMed PMID: 34246341.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - WHO COVID-19 therapeutic guidelines. AU - Rochwerg,Bram, AU - Agoritsas,Thomas, AU - Diaz,Janet, AU - Askie,Lisa, PY - 2021/04/21/received PY - 2021/06/03/accepted PY - 2021/7/11/entrez PY - 2021/7/12/pubmed PY - 2021/7/16/medline SP - 117 EP - 118 JF - Lancet (London, England) JO - Lancet VL - 398 IS - 10295 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/34246341/WHO_COVID-19_therapeutic_guidelines. L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(21)01331-3 DB - PRIME DP - Unbound Medicine ER -